Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Director Dealing and CLN Conversion - Correction

10 Dec 2020 10:41

RNS Number : 2271I
IQ-AI Limited
10 December 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

Director Dealing and Conversion of Loan Notes - Correction

The following amendments have been made to the "Director Dealing and Conversion of Loan Notes" announcement released on 9 December at 09:02 a.m.

The Company has also received a conversion notice from Trevor Brown, converting £90,000 convertible loan notes and the £8,100 associated interest, issued in May 2019, at a price of 1.5 pence, into 6,540,000 Ordinary Shares.

 

Following Admission, the Company will have 170,107,609 ordinary shares of 0.01p each in issue and Trevor Brown will be directly and indirectly interested in approximately 29.28 per cent of the Company's enlarged issued ordinary share capital.

All other details remain unchanged. The full amended text is shown below.

IQ-AI Ltd

("IQ-AI" or the "Company")

Director Dealing and Conversion of Loan Notes

 

IQ-AI Ltd has received a conversion notice from Trevor Brown, the CEO of IQ-AI, converting £50,000 convertible loan notes and the £5,250 associated interest, issued in March 2019, at a price of 2 pence, into 2,762,500 Ordinary Shares.

 

In addition, the Company has also received a conversion notice from Trevor Brown, converting £90,000 convertible loan notes and the £8,100 associated interest, issued in May 2019, at a price of 1.5 pence, into 6,540,000 Ordinary Shares.

 

In total, Trevor Brown will indirectly or directly be issued a total of 9,302,500 Ordinary Shares (the "CLN Shares"). In addition, Trevor Brown has sold 1,900,000 Ordinary Shares in the Company.

 

Following the above transactions, Trevor Brown will be directly and indirectly interested in 49,813,236 Ordinary Shares, representing approximately 29.28 per cent. of the Company's enlarged issued ordinary share capital. 

 

An application will be made for the 9,302,500 CLN Shares to be admitted to the Official List of the UK Listing Authority by way of a Standard Listing ("Admission") and it is expected that Admission will become effective and that dealing in the CLN Shares will commence on or around 8am on 15 December 2020. The CLN Shares will rank pari passu with the existing ordinary shares of the Company.

 

Following Admission, the Company will have 170,107,609 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 170,107,609.

 

The above figure of 170,107,609 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Trevor Brown

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 IQ-AI Limited

b)

LEI

213800SPW48XRJS2QH57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share JE00BD4H0R42

b)

Nature of the transaction

Sale of shares

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

9.57p

8.5p

1,100,000

800,000

d)

Aggregated information

· Aggregated volume

· Price

 

1,900,000

9.04p

e)

Date of the transaction

7 and 8 December 2020

f)

Place of the transaction

London Stock Exchange Main Market

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Trevor Brown

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 IQ-AI Limited

b)

LEI

213800SPW48XRJS2QH57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share JE00BD4H0R42

b)

Nature of the transaction

Conversion of loan into shares

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

2p

1.5p

2,762,500

6,540,000

d)

Aggregated information

· Aggregated volume

· Price

 

N/A

e)

Date of the transaction

9 December 2020

f)

Place of the transaction

London Stock Exchange Main Market

     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHURORRRWUUAAA
Date   Source Headline
1st Jun 20207:00 amRNSIB Awarded $2.57m grant
19th May 20209:19 amRNSNotice of AGM
4th May 202010:04 amRNSFinal Results
30th Apr 20201:08 pmRNSDelay in Publishing Final Year Accounts
18th Mar 20202:34 pmRNSIB's Software featured in award-winning article
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20201:42 pmRNSTotal Voting Rights
5th Feb 20204:30 pmRNSConversion of Loan Notes - Correction
5th Feb 20203:20 pmRNSConversion of Loan Notes
27th Jan 20209:29 amRNSImaging Biometrics Adds to Development Team
20th Jan 20207:00 amRNSKFDA Clearance for StoneChecker Software
13th Jan 202011:35 amRNSExercise of Options
9th Jan 20207:00 amRNSImaging Biometrics Partners with AI Metrics
18th Dec 201912:46 pmRNSBoard Changes and Restructuring Initiatives
7th Nov 20197:01 amRNSInitiation of IB Stroke Project
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 20192:05 pmRNSSecond Price Monitoring Extn
1st Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 201911:05 amRNSSecond Price Monitoring Extn
1st Oct 201911:00 amRNSPrice Monitoring Extension
1st Oct 20199:05 amRNSSecond Price Monitoring Extn
1st Oct 20199:00 amRNSPrice Monitoring Extension
1st Oct 20197:01 amRNSStoneChecker USA Market Introduction
1st Oct 20197:00 amRNSIssue of Equity
30th Sep 201911:05 amRNSSecond Price Monitoring Extn
30th Sep 201911:00 amRNSPrice Monitoring Extension
27th Sep 20197:00 amRNSFDA Clearance to Market for StoneChecker Software
16th Sep 20199:34 amRNSReplacement - Half Yearly Report to 30 June 2019
16th Sep 20197:00 amRNSHalf-year Report
4th Sep 20197:00 amRNSGrant Award
6th Aug 20197:00 amRNSCompletion of Placing and Conversion of Loan Notes
5th Aug 20192:05 pmRNSSecond Price Monitoring Extn
5th Aug 20192:00 pmRNSPrice Monitoring Extension
9th Jul 20197:00 amRNSUpdate on Gadolinium Free Imaging Project
26th Jun 20197:00 amRNSPlacing
24th Jun 20192:52 pmRNSHolding(s) in Company
20th Jun 20194:40 pmRNSSecond Price Monitoring Extn
20th Jun 20194:35 pmRNSPrice Monitoring Extension
12th Jun 20197:00 amRNSBusiness Development Agreement with CorTechs Labs
6th Jun 201911:49 amRNSResult of AGM
29th May 201911:51 amRNSIssue of Convertible Loan Notes - Correction
29th May 20198:22 amRNSIssue of Convertible Loan Notes
17th May 201912:00 pmRNSExtension of Loan Notes Redemption Date
9th May 20191:30 pmRNSNotice of AGM
9th May 201912:13 pmRNSHolding(s) in Company
30th Apr 201912:00 pmRNSPublication of Annual Report
2nd Apr 20197:00 amRNSImaging Biometrics Update
11th Mar 20197:00 amRNSIssue of Convertible Loan Notes
8th Feb 201910:29 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.